Newsletter

Subscribe and receive updates on this company

Text STOCKS to 72727 for mobile alerts

We are excited to present Curis, Inc. (NASDAQ: CRIS).

Full DD Report for CRIS

You must become a subscriber to view this report.


Recent News from (NASDAQ: CRIS)

Curis' (CRIS) CEO Ali Fattaey on Q1 2018 Results - Earnings Call Transcript
Curis, Inc. (CRIS) Q1 2018 Earnings Conference Call May 3, 2018 08:30 AM ET Executives James Dentzer - CFO and CAO Ali Fattaey - President and CEO Analysts Adnan Butt - Guggenheim Securities Peter Lawson - SunTrust Robinson Humphrey Presentation Operator Good mo...
Source: SeekingAlpha
Date: May, 03 2018 11:00
Curis Reports First Quarter 2018 Financial Results
LEXINGTON, Mass. , May 3, 2018 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development and commercialization of innovative and effective therapeutics for the treatment of cancer, today reported its financial results for the first quarter ende...
Source: PR Newswire
Date: May, 03 2018 07:00
Curis to Release First Quarter 2018 Financial Results and Hold Conference Call on May 3, 2018
LEXINGTON, Mass. , April 26, 2018 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development and commercialization of innovative and effective therapeutics for the treatment of cancer, today announced that the Company will release its first qu...
Source: PR Newswire
Date: April, 26 2018 07:00
Free Post Earnings Research Report: Curis' Quarterly Revenue Jumped 38.10%
Stock Monitor: Aldeyra Therapeutics Post Earnings Reporting LONDON, UK / ACCESSWIRE / April 19, 2018 / Active-Investors.com has just released a free earnings report on Curis, Inc. (NASDAQ: CRIS ). If you want access to this report all you need to do is sign up now by clicking the fo...
Source: ACCESSWIRE IA
Date: April, 19 2018 07:50
Investor Expectations to Drive Momentum within Atrion, Curis, Independence Contract Drilling, Utah Medical Products, FutureFuel, and Opiant Pharmaceuticals - Discovering Underlying Factors of Influence
NEW YORK, April 03, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Atrion Corporation (NASDAQ:ATRI), Curis, Inc. (NASDAQ:CRIS), Independenc...
Source: GlobeNewswire
Date: April, 03 2018 08:00
Curis: Time To Bet On A Courageous Choice
In one of my previous articles , I have given you an overview about Curis Inc. ( CRIS ), exposing all the reasons that made it risky but attractive. Today I want to set out what has changed between then and now and why I believe that is time to buy. I will start off by getting you up to spe...
Source: SeekingAlpha
Date: March, 20 2018 10:28
Curis (CRIS) Presents At 38th Annual Cowen And Company Healthcare Conference - Slideshow
The following slide deck was published by Curis, Inc. in conjunction with this Read more ...
Source: SeekingAlpha
Date: March, 15 2018 14:03
Curis' (CRIS) CEO Ali Fattaey on Q4 2017 Results - Earnings Call Transcript
Curis, Inc. (CRIS) Q4 2017 Earnings Conference Call March 8, 2018 8:30 AM ET Executives James Dentzer - Chief Financial Officer and Chief Administrative Officer Ali Fattaey - President and Chief Executive Officer Analysts Adnan Butt - Guggenheim Securities Brian Skorney - R...
Source: SeekingAlpha
Date: March, 08 2018 13:00
Curis Q4 revenues up 38%; shares ahead 11% premarket
Curis ( CRIS ) Q4 results : Revenues: $3.3M (+37.5%); R&D Expense: $1M (0.0%); SG&A: $1M (0.0%); Operating Loss: ($7.1M) (+34.3%); Net Loss: ($8M) (+29.2%); Loss Per Share: ($0.05) (+37.5%); Quick Assets: $60.2M (+35.3%). More news on: Curis, Inc., Healthcare stocks news, Earnings...
Source: SeekingAlpha
Date: March, 08 2018 09:01
Curis, Inc. 2017 Q4 - Results - Earnings Call Slides
The following slide deck was published by Curis, Inc. in conjunction with their 2017 Q4 earnings Read more ...
Source: SeekingAlpha
Date: March, 08 2018 08:45

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-05-180.56540.54990.5690.5424625,429
2018-05-170.55730.54990.580.536592,537
2018-05-160.570.56730.5830.5227844,088
2018-05-150.610.5680.620.55561,353,981
2018-05-140.530.60650.620.522,741,877

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-05-1886,455303,92628.4461Cover
2018-05-1791,215221,00441.2730Short
2018-05-16166,545374,65344.4531Short
2018-05-15369,545708,21252.1800Short
2018-05-14680,0011,568,85243.3439Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on CRIS.


About Curis, Inc. (NASDAQ: CRIS)

Logo for Curis, Inc. (NASDAQ: CRIS)

Not available

 

Contact Information

 

 

Current Management

  • Doros Platika / CEO
  • George A. Eldridge / CFO

Current Share Structure

  • Market Cap: $86,689,889 - 05/11/2018
  • Issue and Outstanding: 165,628,371 - 03/02/2018

 


Recent Filings from (NASDAQ: CRIS)

Notice from the SEC of registration effectiveness
Filing Type: EFFECTFiling Source: edgar
Filing Date: May, 17 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 03 2018
Simplified registration form
Filing Type: S-3Filing Source: edgar
Filing Date: May, 03 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 03 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: April, 03 2018
Additional proxy soliciting materials - definitive
Filing Type: DEFA14AFiling Source: edgar
Filing Date: April, 03 2018
Preliminary proxy statement providing notification matters to be brought to a vote
Filing Type: PRE 14AFiling Source: edgar
Filing Date: March, 23 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 22 2018
Filing Type: CT ORDERFiling Source: edgar
Filing Date: March, 12 2018
Filing Type: CT ORDERFiling Source: edgar
Filing Date: March, 12 2018

 

 


Daily Technical Chart for (NASDAQ: CRIS)

Daily Technical Chart for (NASDAQ: CRIS)


Stay tuned for daily updates and more on (NASDAQ: CRIS)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: CRIS)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

Monsta Trader
@MonstaTrader

 

 


Disclaimer: Monsta Trader publishes reports providing information on selected companies. Monsta Trader is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. Monsta Trader accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in CRIS is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. Monsta Trader has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. Monsta Trader does not own any shares of CRIS and does not buy, sell, or trade any shares of CRIS. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by Monsta Trader. All rights reserved. Our Full Disclaimer: http://monstatrader.com/disclaimer/